跳至主要内容
临床试验/NCT02029196
NCT02029196已完成不适用

A Randomised, Parallel Group, Multi-centre Study to Evaluate the Safety Profile of the ITG EVP G1 Product

Imperial Brands PLC4 个研究点 分布在 1 个国家目标入组 408 人开始时间: 2013年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
408
试验地点
4
主要终点
Adverse Events

研究概览

简要总结

Electronic Vapour Products (EVPs) is a relatively new class of consumer products that are otherwise known as electronic cigarettes or electronic nicotine delivery devices/systems. These may look like conventional cigarettes but do not contain tobacco.

The 'vapour' produced by such devices typically consists of humectants (propylene glycol or glycerol), nicotine, water, and flavours.

This trial is to evaluate the safety of an e-vapour product.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Body Mass Index (BMI) of 18-35kg/m2
  • Subjects must be established smokers
  • Subjects must have smoked five to 30 cigarettes per day for at least one year

排除标准

  • Subjects who have used nicotine replacement therapy within 14 days of the screening
  • Subjects who have donated blood within 12 months preceding study
  • Subjects with relevant illness history
  • Subjects positive for hepatitis or Human Immunodeficiency Virus (HIV)
  • Subjects with history of drug or alcohol abuse
  • Subjects with lung function test or vital signs considered unsuitable
  • Subjects who are trying to stop smoking
  • Female subjects who are pregnant, or unwilling to use acceptable contraceptive method for the duration of the study.

结局指标

主要结局

Adverse Events

时间窗: 12 weeks

Frequency of adverse events

次要结局

  • Exhaled Carbon Monoxide(12 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

A Study to Evaluate the Safety Profile of an... | 临床试验